<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001639'>Hypertrophic cardiomyopathy</z:hpo> is a common inherited <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> present in one in 500 of the general population </plain></SENT>
<SENT sid="1" pm="."><plain>It is caused by more than 1400 mutations in 11 or more genes encoding proteins of the cardiac sarcomere </plain></SENT>
<SENT sid="2" pm="."><plain>Although <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> is the most frequent cause of <z:hpo ids='HP_0001699'>sudden death</z:hpo> in young people (including trained athletes), and can lead to functional disability from <z:hpo ids='HP_0001635'>heart failure</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo>, the majority of affected individuals probably remain undiagnosed and many do not experience greatly reduced life expectancy or substantial symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical diagnosis is based on otherwise unexplained <z:hpo ids='HP_0001712'>left-ventricular hypertrophy</z:hpo> identified by echocardiography or cardiovascular MRI </plain></SENT>
<SENT sid="4" pm="."><plain>While presenting with a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> clinical profile and complex pathophysiology, effective treatment strategies are available, including implantable defibrillators to prevent <z:hpo ids='HP_0001699'>sudden death</z:hpo>, drugs and surgical myectomy (or, alternatively, alcohol septal ablation) for relief of outflow obstruction and symptoms of <z:hpo ids='HP_0001635'>heart failure</z:hpo>, and pharmacological strategies (and possibly radiofrequency ablation) to control <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and prevent embolic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>A subgroup of patients with genetic mutations but without <z:hpo ids='HP_0001712'>left-ventricular hypertrophy</z:hpo> has emerged, with unresolved natural history </plain></SENT>
<SENT sid="6" pm="."><plain>Now, after more than 50 years, <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> has been transformed from a rare and largely untreatable disorder to a common <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disease</z:e> with management strategies that permit realistic <z:hpo ids='HP_0002835'>aspirations</z:hpo> for restored quality of life and advanced longevity </plain></SENT>
</text></document>